AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $14,000 | -48.1% | 505 | -30.4% | 0.00% | -50.0% |
| Q2 2019 | $27,000 | +575.0% | 726 | +578.5% | 0.00% | – |
| Q1 2019 | $4,000 | -33.3% | 107 | -63.2% | 0.00% | -100.0% |
| Q4 2018 | $6,000 | -90.9% | 291 | -82.6% | 0.00% | -80.0% |
| Q3 2018 | $66,000 | -98.7% | 1,676 | +1209.4% | 0.01% | – |
| Q2 2018 | $4,891,000 | +48810.0% | 128 | -61.2% | 0.00% | -100.0% |
| Q1 2018 | $10,000 | +11.1% | 330 | +14.2% | 0.00% | 0.0% |
| Q4 2017 | $9,000 | +200.0% | 289 | +151.3% | 0.00% | – |
| Q3 2017 | $3,000 | 0.0% | 115 | -12.2% | 0.00% | – |
| Q2 2017 | $3,000 | +50.0% | 131 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | – | 131 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,806,832 | $34,582,764,000 | 27.20% |
| Casdin Capital, LLC | 400,000 | $7,652,000 | 2.83% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,729,268 | $33,081,000 | 1.76% |
| Redmile Group, LLC | 1,459,616 | $27,922,000 | 1.70% |
| Opaleye Management Inc. | 150,000 | $2,869,000 | 1.20% |
| Cormorant Asset Management, LP | 323,545 | $6,189,000 | 1.03% |
| Orbimed Advisors | 4,801,638 | $91,855,000 | 0.96% |
| Perceptive Advisors | 707,500 | $13,534,000 | 0.68% |
| Rock Springs Capital Management LP | 595,200 | $11,386,000 | 0.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,000 | $2,870,000 | 0.49% |